Inclusion Criteria:~* Meets the National Institute of Neurological and Communicative Diseases and
Stroke/Alzheimers Disease and Related Disorders Association (NINCDS-ADRDA) criteria for Alzheimers disease,
regardless of date of diagnosis relative to study entry date.~* Has an Alzheimers disease status of mild to
moderate, as classified by a Mini Mental State Examination (MMSE) score of 16 - 26 inclusive at screening.~*
Post-menopausal females defined as menopause is defined as >6 months without menstrual period with an
appropriate clinical profile, e.g. age appropriate, history of vasomotor symptoms. However if indicated this
should be confirmed by oestradiol and FSH levels consistent with menopause (according to local laboratory
ranges).~* Women who are on HRT (hormone replacement therapy) treatment, and have not been confirmed as
post-menopausal should be advised to use contraception.~* Has a permanent caregiver who is willing to attend
all visits, oversee the subjects compliance with protocol-specified procedures and study medication, and report
on subjects status. (Subjects living alone or in a nursing home are not eligible).~
